2016年1月全球药品研发进展取得成效的药物共有40个,比2015年12月大幅减少33个。进入注册阶段的有23个,较上月增加3个。其中,4个为全球首次注册的药品,在新市场补充注册的为19个。进入注册前阶段的有9个,较上月减少3个。进入Ⅲ期临床研究阶段的有8个,较上月大幅减少33个。 In January 2016, the number of drugs that made progress in global drug development progress was 40, a sharp decrease of 33 from December 2015. There were 23 entries into the registration stage, an increase of 3 from the previous month. Of these, 4 were the first drugs registered in the world and 19 were newly registered in the new market. There were 9 before entering the registration stage, 3 less than the previous month. There were eight clinical trials entering stage III, a sharp decrease of 33 from the previous month.